NCT04060979 - Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 6, 2019

Primary Completion Date

March 2, 2020

Study Completion Date

April 2, 2020

Conditions

Bronchiolitis Acute

Interventions

DRUG

Nitric Oxide

Nitric Oxide given intermittently via inhalation

OTHER

Standard Supportive treatment

Standard Supportive treatment (including oxygen)

Trial Locations (7)

Haemek Medical Center, Afula

Assuta Ashdod, Ashdod

Soroka Medical Center, Beersheba

Carmel MEdical Center, Haifa

Shaarei Zedek Medical Center, Jerusalem

Schneider Children's hospital, Petah Tikva

Sheba Medical Center, Tel Litwinsky